Tocilizumab for severe COVID-19: a promising intervention affecting inflammation and coagulation.
Eur J Intern Med. 2020 May 16;:
Authors: Levi M
PMID: 32425364 [PubMed - as supplied by publisher]
Tocilizumab for severe COVID-19: a promising intervention affecting inflammation and coagulation.
Eur J Intern Med. 2020 May 16;:
Authors: Levi M
PMID: 32425364 [PubMed - as supplied by publisher]